Researchers at the University of Liverpool have shown how SARS-CoV-2 viral proteases attack the host cell, and how this can be targeted to stop virus replication in cell culture using existing drugs.
Click here for original story, Inhibiting targets of SARS-CoV-2 proteases can block infection, study shows
Source: Phys.org